Kerberos Rinspiration System Receives Additional FDA Clearance
Mountain View, Calif. – Sep 10, 2004
Kerberos Proximal Solutions Inc. has received clearance from the U.S. Food and Drug Administration for coronary and peripheral use of the Rinspiration System™. “Rinspiration” is focal simultaneous rinsing and aspiration administered by a single catheter. This clearance accelerates Kerberos’ ability to support physician interest in the United States.
“The 6French compatible Rinspiration System from Kerberos combines simple set-up and use with a very high level of efficiency compared to available aspiration catheters. It will be a valuable addition to our interventional tool kit,” said Dr. Donald S. Baim, professor of medicine, Harvard Medical School and Director of the Center for Integration of Medicine and Innovative Technology at Brigham and Women’s Hospital, Boston, Mass.
The Rinspiration System will be exhibited at the Transcatheter Cardiovascular Therapeutics (TCT) conference Sept. 27 – Oct. 1, 2004. Clinical data from studies in Canada and Germany will be presented at TCT by Dr. John Webb and Professor Eberhard Grube, respectively.
“We are pleased to add the coronary indication for this catheter to our family of Rinspiration- based products,” said John MacMahon, president and chief executive officer of Kerberos.
Kerberos Chairman Carl Simpson, an early pioneer in interventional cardiology, said the Rinspiration System represents technology that optimizes the efficiency of aspiration.
“With further investigations and studies, this platform has the potential to demonstrate big savings of time, myocardium and money,” Simpson said.
Kerberos will sponsor a breakfast symposium at TCT, moderated by Dr. Baim, entitled: “Rinspiration™ for Vascular Lavage: Technology, Techniques and Clinical Results.” All interested physicians are welcome to attend the session Friday, Oct. 1, from 7 a.m. to 8 a.m., and may register for the symposium and find more information on Kerberos at TCT at the Kerberos Proximal Solutions website: www.kerberos-md.com.
Kerberos Proximal Solutions endeavors to develop products for improved vascular treatment.